ATE150973T1 - Chinoloncarbonsäure-metallionsäurekomplexe - Google Patents

Chinoloncarbonsäure-metallionsäurekomplexe

Info

Publication number
ATE150973T1
ATE150973T1 AT91902370T AT91902370T ATE150973T1 AT E150973 T1 ATE150973 T1 AT E150973T1 AT 91902370 T AT91902370 T AT 91902370T AT 91902370 T AT91902370 T AT 91902370T AT E150973 T1 ATE150973 T1 AT E150973T1
Authority
AT
Austria
Prior art keywords
acid
quinoloonecarbonic
complexes
metallic
compositions
Prior art date
Application number
AT91902370T
Other languages
English (en)
Inventor
Laman A Al-Razzak
Francisco J Alvarez
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23822659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE150973(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE150973T1 publication Critical patent/ATE150973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/069—Aluminium compounds without C-aluminium linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT91902370T 1989-12-29 1990-12-20 Chinoloncarbonsäure-metallionsäurekomplexe ATE150973T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45892789A 1989-12-29 1989-12-29
PCT/US1990/007584 WO1991009525A1 (en) 1989-12-29 1990-12-20 Quinolone carboxylic acid--metal ion--acid complexes

Publications (1)

Publication Number Publication Date
ATE150973T1 true ATE150973T1 (de) 1997-04-15

Family

ID=23822659

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91902370T ATE150973T1 (de) 1989-12-29 1990-12-20 Chinoloncarbonsäure-metallionsäurekomplexe

Country Status (14)

Country Link
US (1) US5334589A (de)
EP (1) EP0507851B1 (de)
JP (1) JP3153549B2 (de)
AT (1) ATE150973T1 (de)
AU (1) AU647772B2 (de)
CA (1) CA2072366C (de)
DE (1) DE69030387T2 (de)
DK (1) DK0507851T3 (de)
ES (1) ES2102393T3 (de)
GR (1) GR3023542T3 (de)
IE (1) IE904725A1 (de)
IL (1) IL96776A (de)
PT (1) PT96400B (de)
WO (1) WO1991009525A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118183D0 (en) * 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US6024979A (en) * 1995-06-06 2000-02-15 Solvay Animal Health, Inc. Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant
EP0868183B1 (de) * 1995-12-21 2002-01-30 Pfizer Inc. Injizierbare quinolonformulierungen
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE10018781A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit
AU2005258398A1 (en) * 2004-07-02 2006-01-12 Daiichi Pharmaceutical Co., Ltd. Quinolone-containing medicinal composition
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
KR101959873B1 (ko) 2008-10-07 2019-03-19 랩터 파마슈티컬스 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
WO2011029059A1 (en) 2009-09-04 2011-03-10 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis
WO2016195020A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
JP6031217B1 (ja) 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
JP6031216B1 (ja) 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
CN105524060B (zh) * 2016-03-10 2017-03-22 青岛云天生物技术有限公司 一种制备盐酸莫西沙星的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JP2832535B2 (ja) * 1989-04-04 1998-12-09 富山化学工業株式会社 キノロンカルボン酸またはその塩の可溶化法
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.

Also Published As

Publication number Publication date
AU647772B2 (en) 1994-03-31
AU7153191A (en) 1991-07-24
JP3153549B2 (ja) 2001-04-09
DE69030387T2 (de) 1997-10-23
WO1991009525A1 (en) 1991-07-11
DE69030387D1 (de) 1997-05-07
CA2072366A1 (en) 1991-06-30
IL96776A (en) 1997-02-18
IL96776A0 (en) 1991-09-16
JPH05502879A (ja) 1993-05-20
IE904725A1 (en) 1991-07-17
US5334589A (en) 1994-08-02
EP0507851B1 (de) 1997-04-02
EP0507851A4 (en) 1993-03-17
ES2102393T3 (es) 1997-08-01
CA2072366C (en) 2002-08-20
DK0507851T3 (da) 1997-08-25
EP0507851A1 (de) 1992-10-14
GR3023542T3 (en) 1997-08-29
PT96400B (pt) 1998-06-30
PT96400A (pt) 1991-10-15

Similar Documents

Publication Publication Date Title
ATE150973T1 (de) Chinoloncarbonsäure-metallionsäurekomplexe
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
MY110734A (en) Improvements in or relating to dioic acids.
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
DE3880587D1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
HUT45521A (en) Process for producing quinolinecarboxylic acid derivatives
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
SE8701077D0 (sv) Pharmaceutical composition
ATE31022T1 (de) Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten.
DE68928488D1 (de) Zusammensetzungen und verabreichungsverfahren für heilmittel
DK15088D0 (da) Antibakterielt lyofiliseret praeparat
ATE173925T1 (de) Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
KR890001555A (ko) 요산 배설용 조성물
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
ATE90204T1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
UA10219A (uk) Спосіб лікування туберкульозу легень

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time